Medical Devices & Implant

UNM Surgeon Introduces Advanced Thumb Joint Replacement Procedure for Arthritis Patients

The procedure is comparable to hip and knee replacement surgeries, where a prosthetic implant is used to replace damaged joint surfaces...

Aevice Health Partners With Parkway MediCentre to Roll Out Home-Based Paediatric Asthma Monitoring Programme

The programme uses the AeviceMD Monitoring System to support home-based respiratory monitoring for children during sleep...

Lupin Receives Approval from U.S. FDA for Ranluspec (ranibizumab) Injection

Ranibizumab is a recombinant humanised IgG1 monoclonal antibody fragment that binds and inhibits vascular endothelial growth factor A...

Reach Surgical Receives CE Mark Approval for SOUND REACH Swift

The leading innovative plug-and-play ultrasonic shears with an integrated transducer are designed for open surgery...

Mindray expands Hepatus-Series ultrasound systems for gastroenterology imaging

The upgraded Hepatus-Series integrates ultrasound and elastography to support liver, bowel and spleen assessment within a unified imaging workflow....

SWS Medical Unveils Next-Generation Renal Innovation at ERA 2026

At ERA 2026, the company will showcase the next generation of dialysis and CRRT platforms designed to support intelligent automation, connected care, workflow efficiency, and integrated therapy delivery...

Intuitive Announces Innovations to Advance Quintuple Aim

Latest innovations include enhanced telecollaboration capabilities, extended uses for Force Feedback technology, and advancements in product and instrument reliability and security...

Spinal Resources Secures Second US Patent for Multi-Diameter Spinal Fixation Rod

The new patent expands protection around Spinal Resources’ variable-stiffness spinal fixation platform, strengthening its intellectual property position across the rod, implant system, and AI-enabled patient-specific design methodology. ...

Chance Pharma’s CXG87 Moves Into China Regulatory Review for Asthma Treatment

The NMPA acceptance of Chance Pharma’s first new drug application advances CXG87, an improved budesonide/formoterol dry powder inhalation therapy, toward potential commercialisation in China. ...